1-amino-4-bromoanthraquinone-2-sulfonic acid sodium salt

Suppliers

Names

[ CAS No. ]:
6258-06-6

[ Name ]:
1-amino-4-bromoanthraquinone-2-sulfonic acid sodium salt

[Synonym ]:
Sodium 1-amino-4-bromo-9,10-dioxo-9,10-dihydro-2-anthracenesulfonate
EINECS 228-391-5
MFCD00019160
2-Anthracenesulfonic acid, 1-amino-4-bromo-9,10-dihydro-9,10-dioxo-, sodium salt (1:1)
Sodium 1-amino-4-bromo-9,10-dioxo-9,10-dihydroanthracene-2-sulfonate
sodium,1-amino-4-bromo-9,10-dioxoanthracene-2-sulfonate

Chemical & Physical Properties

[ Melting Point ]:
>300 °C(lit.)

[ Molecular Formula ]:
C14H7BrNNaO5S

[ Molecular Weight ]:
404.168

[ Exact Mass ]:
402.912598

[ PSA ]:
125.74000

[ LogP ]:
3.37280

MSDS

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
CB1090000
CHEMICAL NAME :
2-Anthracenesulfonic acid, 9,10-dihydro-1-amino-4-bromo-9,10-dioxo-, sodium salt
CAS REGISTRY NUMBER :
6258-06-6
LAST UPDATED :
199710
DATA ITEMS CITED :
4
MOLECULAR FORMULA :
C14-H7-Br-N-O5-S.Na
MOLECULAR WEIGHT :
404.18
WISWESSER LINE NOTATION :
L C666 BV IVJ DZ ESWO GE &-NA-

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
Standard Draize test
ROUTE OF EXPOSURE :
Administration into the eye
SPECIES OBSERVED :
Rodent - rabbit
REFERENCE :
85JCAE "Prehled Prumyslove Toxikologie; Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 Volume(issue)/page/year: -,1062,1986

Safety Information

[ Symbol ]:

GHS07

[ Signal Word ]:
Warning

[ Hazard Statements ]:
H315-H319-H335

[ Precautionary Statements ]:
P261-P305 + P351 + P338

[ Personal Protective Equipment ]:
dust mask type N95 (US);Eyeshields;Gloves

[ Hazard Codes ]:
Xi

[ Risk Phrases ]:
36/37/38

[ Safety Phrases ]:
S26-S36

[ RIDADR ]:
NONH for all modes of transport

[ WGK Germany ]:
1

[ RTECS ]:
CB1090000

Synthetic Route

Precursor & DownStream

Precursor

  • Fast Red AL
  • 2-Anthracenesulfonicacid, 1-amino-9,10-dihydro-9,10-dioxo-

DownStream

  • 2-Anthracenesulfonicacid, 1-amino-9,10-dihydro-9,10-dioxo-4-(phenylamino)-
  • 1-amino-9,10-dihydro-4-hydroxy-9,10-dioxoanthracene-2-sulphonic acid
  • Acid Blue 40
  • 1-Amino-4-bromo anthraquinone
  • 2-Anthraquinonesulfonic acid
  • sodium 1-amino-4-hydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulfonate
  • Acid Blue 25
  • procion blue MX-R
  • 1-amino-4-(methylamino)-9,10-dioxo-9,10-dihydroanthracene-2-sulfonic acid
  • sodium 1-amino-9,10-dihydro-9,10-dioxo-4-o-toluidinoanthracene-2-sulphonate

Articles

Degradation of bromamine acid by nanoscale zero-valent iron (nZVI) supported on sepiolite.

Water Sci. Technol. 66(12) , 2539-45, (2012)

Sepiolite, a natural nano-material, was chosen as a carrier to prepare supported nanoscale zero-valent iron (nZVI). The effects of preparation conditions, including mass ratio of nZVI and activated se...

Convergent synthesis of the potent P2Y receptor antagonist MG 50-3-1 based on a regioselective Ullmann coupling reaction.

Molecules 17(3) , 2599-615, (2012)

MG 50-3-1 (3, trisodium 1-amino-4-{4-[4-chloro-6-(2-sulfophenylamino)-1,3,5-triazin-2-ylamino]-2-sulfophenylamino}-9,10-dioxo-9,10-dihydroanthracene 2-sulfonate) is the most potent and selective antag...

[Treatment of bromoamine acid wastewater by combined ALR-BAC process].

Huan Jing Ke Xue 30(10) , 2930-5, (2009)

Combined ALR-BAC was used to treat bromoamine acid wastewater. The results showed that the ALR system could run steadily for over 1 months at the BAA concentration 650 mg x L(-1) after one-month accli...


More Articles


Related Compounds

  • 4-(4-{4-[(5-Methylpyrimidin-2-yl)oxy]piperidine-1-carbonyl}benzenesulfonyl)morpholine
  • 2-{1-[(1-methyl-1H-pyrazol-4-yl)sulfonyl]piperidin-4-yl}-6-phenyl-2,3-dihydropyridazin-3-one
  • 1-{5-Methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl}-4-[3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]-1,4-diazepane
  • 3-Cyclobutyl-6-[4-(1-methylimidazol-2-yl)sulfonyl-1,4-diazepan-1-yl]-[1,2,4]triazolo[4,3-b]pyridazine
  • 4-{[1-(2-Methyl-1,3-thiazole-4-carbonyl)piperidin-4-yl]methoxy}-6-phenylpyrimidine
  • 4-{4-[(5-Cyclopropyl-1,3,4-oxadiazol-2-yl)methyl]piperazin-1-yl}-5-fluoro-6-(4-methoxyphenyl)pyrimidine
  • 2-{1-[(1,2-dimethyl-1H-imidazol-4-yl)sulfonyl]piperidin-4-yl}-6-phenyl-2,3-dihydropyridazin-3-one
  • 5-fluoro-4-{4-[(1-methyl-1H-imidazol-4-yl)sulfonyl]piperazin-1-yl}-6-phenylpyrimidine
  • N-methyl-N-{1-[3-(pyridin-3-yl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]azetidin-3-yl}pyrimidin-2-amine
  • N,3-Dimethyl-N-[1-(3-pyridin-3-yl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)azetidin-3-yl]-1,2,4-thiadiazol-5-amine
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.